Effect of Neurophysiological Facilitation Techniques in Intensive Care Patients

NCT ID: NCT05282576

Last Updated: 2022-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-01

Study Completion Date

2020-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to investigate the effect of neurophysiological facilitation techniques on respiratory and functional levels in intensive care patients. Participants were divided into two groups as experimental (n=20) and control (n=20). Conventional physiotherapy, which includes chest physiotherapy, mobilization exercises and range of motion exercises were applied in control group. Neurophysiological facilitation techniques in addition to the conventional physiotherapy program ere applied in experimental group. The functional status, lower and upper extremity muscle strength, grip strength measurements of the patients and the rates of weaning from mechanical ventilation were evaluated before and after treatment. Vital signs, dyspnea and fatigue perception were assessed each day of treatment. Evaluations were analyzed statistically using Statistical Package for the Social Sciences-22 program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The intensive care unit is a multidisciplinary unit in which patients with acute, life-threatening organ dysfunction or under risk are monitored and treated comprehensively. Advanced technology is used for follow-up and treatment in intensive care. These supports decrease the mortality rate. However, the increase length of stay in the ICU leads to higher hospital costs in addition to serious secondary pathologies. Prolonged immobilisation in the intensive care unit(ICU); causes the loss of muscle mass and strength of the patients. When the course of illness, the medical devices used, various medications, malnutrition and other reasons such as sepsis are accompanied by this immobilization, the disorder called Intensive Care Acquired Muscle Weakness (ICU-AW) occurs. This neuromuscular disorder, also causes functional impairments after ICU discharge.

Early physiotherapy intervention in ICU, has a positive effect on the symptoms frequently occur in patients. In addition to improve the functional status of the patient such as exercise capacity, muscle strength and mobilization, its increase weaning from mechanical ventilation, and decrease the length of stay in the ICU and hospital. It also provides airway clearance, reduction the work of breathing and improvement of respiratory function.

Neurophysiological facilitation of respiration is the use of proprioceptive and tactile stimulation that produce reflexive movement responses. These responses provide to increase the depth of breathing, decrease respiratory rate in patients with decreased level of consciousness. It also increase inspiratory expansion of the ribs, epigastric excursion and abdominal muscles tone. In the study conducted Kumar et al. has indicated that neurophysiological facilitation (NPF) techniques improves levels of dyspnea and oxygen saturation (spO2) in Coronavirus patients. It is very important to increase the level of oxygen saturation to rate the mortality. In NPF techniques, respectively the proprioceptors and tactile receptors in the abdominal, intercostals and spinal muscles are affected, phrenic motor neurons are stimulated, thoracic and abdominal excursions are increased and thus provide improves vital parameters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intensive Care (ICU) Myopathy Intensive Care Unit Acquired Weakness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group

We applied neurophysiological facilitation techniques in addition to conventional rehabilitation.

Group Type ACTIVE_COMPARATOR

NPF Group

Intervention Type OTHER

Participants allocated to the experimental group completed until discharged, neurophysiological facilitation(NPF) techniques in addition to conventional physiotherapy.

Control Group

Critical ill patients was applied their conventional physiotherapy

Group Type OTHER

Control Group

Intervention Type OTHER

Critical ill patients was applied their conventional physiotherapy which includes chest physiotherapy and mobilization until discharged

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NPF Group

Participants allocated to the experimental group completed until discharged, neurophysiological facilitation(NPF) techniques in addition to conventional physiotherapy.

Intervention Type OTHER

Control Group

Critical ill patients was applied their conventional physiotherapy which includes chest physiotherapy and mobilization until discharged

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Neurophysiological facilitation techniques in addition to conventional physiotherapy. Conventional physiotherapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinically Unstable
* Participants Over the Age of 18
* Individuals who volunteered to participate in the study or were allowed by their first-degree relatives if they were unconscious.
* Patients who are suitable for physiotherapy by the intensive care specialist.

Exclusion Criteria

* Having coagulation disorder (INR \> 1,5 platelet\<50.000 mm3)
* Having neuromuscular diseases
* Having psychiatric disease or overly agitated (Richmond Agitation Sedation Scale score ≥ +2)
* Having acute stroke
* Having Raised Intracranial Pressure Syndrome symptoms
* Having cardiac and respiratory instability (Respiratory frequency \> 30 breaths/min,Partial pressure of oxygen(PaO₂)\< 65 mmHg , fraction of inspired oxygen(FiO₂)\>%55, Diastolic blood pressure \< 50 mmHg or \> 200 mmHg , Systolic blood pressure \< 80 mmHg or \> 200 mmHg)
* Having hemodynamic instability (intropin dose \> 5 mcg/kg/min)
* Fever
* Malignity
* Shock
* Patients admitted to ICU after cardiac, trauma and surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical Park Hospital Istanbul

OTHER

Sponsor Role collaborator

Saglik Bilimleri Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mehmet Burak Uyaroğlu

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mehmet Burak Uyaroğlu, PT,PhD

Role: STUDY_DIRECTOR

Saglik Bilimleri Universitesi

Yasemin Çırak, Ass.Prof

Role: PRINCIPAL_INVESTIGATOR

Istinye University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istinye University

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Saglik Bilimleri Uni

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.